Kairos Pharma, Ltd.
Biotechnology
Healthcare
KAPA
17.21 M shares
NYSE MKT US
traded
18 Sep 2025
listed
no
open
1.31
52 week high
2.60
high
1.47
52 week low
0.00
previous Close
1.68
P/E ratio
market cap
24.89 M
div yield
0
net incoming
-1.42 M
-12.68 %
net profit margin
-142200000.00 %
0.00 %
operating incoming
-1.46 M
-15.01 %
net change in cash
-582.00 K
-124.83 %
cash on hand
3.03 M
-16.10 %
cost of revenue
40.00 K
0.00 %
top